Metiscan, Inc. Announces Sales Milestone | Metiscan, Inc.
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange
Healthcare Company News Metiscan, Inc. Metiscan, Inc. Announces Sales Milestone

Metiscan, Inc. Announces Sales Milestone

Company News - Metiscan, Inc.
Metiscan, Inc.  , Its Wholly Owned Subsidiary, Reaches 25th Customer

Metiscan, Inc. today announced that its wholly owned subsidiary, Metiscan, Inc. (Metiscan), has reached a significant sales milestone; the Company has secured its 25th customer.

Metiscan, Inc. is a market leader in providing radiology Managed Services that combines Radiology Information System (RIS), Teleradiology and PACS (Picture Archiving and Communication System) for independent diagnostic testing facilities.Metiscan, Inc. launched its web-based radiology information system in the fall of 2005. By the end of 2007, Metiscan, Inc. secured contracts with 16 diagnostic imaging facilities and today announced that it has secured its 25th customer. Metiscan, Inc. is fast becoming a stakeholder in the Texas market place.

Stephen Krim, Metiscan's Director of Sales and Marketing, commented, "While achieving our 25th client is a nice milestone there still remains a wide need for our solution within independent diagnostic testing facilities and rural hospitals across the United States. Many studies point to how a digital RIS/PACS system can be beneficial to the bottom line -- which is important in the midst of declining reimbursements." He continued, "I believe that as long as we continue to demonstrate how our system improves workflow, patient care, and increases profits we will continue to expand and achieve market share."

Bryan A. Scott, Metiscan's President & CEO, comments, "I am rather impressed with Metiscan's success. In just two short years, Metiscan, Inc. has achieved 5% market share in Texas alone, with Texas being one of the largest three markets in the United States. I believe that since Metiscan, Inc. has an established client base and a proven IT solution to build upon, the Company will be able to more rapidly increase its market share not only in Texas but across the United States."

The medical imaging segments are poised for a major new phase of growth fueled by the availability of new technology coupled with the higher interest of individual older baby boom patients and general healthcare consumers to monitor health status. Specifically, the imaging technology market reached $13 billion in the United States in 2005, and analysts project this dynamic medical market to amount to $16.5 billion in 2008. Metiscan's web-based radiology information system is positioned to support this market segment by aiding physicians in managing, distributing, interpreting and archiving images more efficiently while achieving IT savings.

About Metiscan, Inc.
Metiscan, Inc., through its wholly owned subsidiary Metiscan, Inc. (Metiscan), is a national provider of products and services that streamline the management and operation functions of diagnostic imaging facilities, radiology groups, in-office imaging groups, small hospitals and physician offices. Metiscan's keystone product is a web-based radiology information system that interfaces Radiology Information System (RIS), Teleradiology and PACS (Picture Archiving and Communication System) for its clients. Metiscan, Inc. also provides information management and operations support for diagnostic imaging facilities through complete revenue cycle management, electronic medical records or EMR, medical transcription services and functional training as needed.

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause the Metiscan's actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "intends," "anticipates" or "plans" to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.

Source: http://www.metiscan.com